Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations
Therapeutic Advances in Respiratory Disease · 2026-07 · 20
DOI: 10.1177/17534666261459923 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 04.07.2026. Verfasst von Alessandro De Angelis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Hauptthemen laut MEDLINE: Bronchiectasis, Guideline Adherence, Practice Guidelines as Topic, Practice Patterns, Physicians'. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
National quality standards for bronchiectasis in Italy were last defined in 2016. The publication of the 2025 European Respiratory Society (ERS) guidelines offers the opportunity to evaluate current clinical practice against updated evidence-based recommendations.
Objectives
To assess the extent to which Italian bronchiectasis centers align with key statements from the 2025 ERS guidelines.
Design
National, multicenter, cross-sectional observational study based on a structured survey of Italian bronchiectasis centers, aligned with the 2025 ERS recommendations.
Methods
A national survey was conducted across Italian bronchiectasis centers affiliated with the Italian Bronchiectasis Patient Association (AIB). The structured questionnaire assessed center organization, diagnostic resources, multidisciplinary care, and alignment with ten predefined core management domains derived from the 2025 ERS recommendations.
Results
Most centers reported universal access to minimum bundle etiological tests, with improved capacity compared with 2016. However, specialized diagnostics for rare causes, structured physiotherapy programs, and written self-management plans remain inconsistently available. Long-term inhaled antibiotics and macrolides were widely prescribed, though access barriers persist. Monitoring practices were heterogeneous.
Conclusion
Despite clear progress, substantial variability persists in physiotherapy access, rare disease diagnostics, self-management tools, and routine monitoring. Updated Italian quality standards aligned with ERS 2025 principles are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
- IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Milan, Italy.
- Respiratory and Critical Care Unit, IRCCS Sant'Orsola Malpighi Hospital, Bologna, Italy.
- Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
- Internal Medicine Department, Respiratory and Cystic Fibrosis Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy.
ORCID-Profile: Alessandro De Angelis, Salvatore Battaglia, Mattia Nigro
Zitieren
APA
De Angelis, A., Comellini, V., Gramegna, A., Battaglia, S., Montemurro, G., Bellofiore, A., Pagnini, F., Privitera, E., Ori, M., Simonetta, E., Nigro, M., Chalmers, J. D., Nobile, D., Blasi, F., & Aliberti, S. (2026). Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261459923
Vancouver
De Angelis A, Comellini V, Gramegna A, Battaglia S, Montemurro G, Bellofiore A, et al. Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261459923
BibTeX
@article{DeAngelis2026,
author = {De Angelis, Alessandro and Comellini, Vittoria and Gramegna, Andrea and Battaglia, Salvatore and Montemurro, Giuliano and Bellofiore, Angela and Pagnini, Francesco and Privitera, Emilia and Ori, Margherita and Simonetta, Edoardo and Nigro, Mattia and Chalmers, James D and Nobile, Donatella and Blasi, Francesco and Aliberti, Stefano},
title = {Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261459923}
}
EUVIMED